ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.1030
+0.0038 (3.83%)
At close: Sep 4, 2026
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $833.88 thousand as of September 4, 2026. Its market cap has decreased by -20.77% in one year.
Market Cap
833.88K
Enterprise Value
1.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
ChartMarket Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from 95.47M to 833.88K, a decrease of -99.13%. That is a compound annual growth rate of -64.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 833.88K | -22.90% |
| Dec 31, 2025 | 1.08M | -59.32% |
| Dec 31, 2024 | 2.66M | -43.66% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
| Feb 10, 2022 | 95.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vaxxinity | 1.27M |
| Regenerative Medical Technology Group | 1.12M |
| Innovation Pharmaceuticals | 1.06M |
| Evofem Biosciences | 993.98K |
| Neon Bloom | 955.17K |
| Agentix | 801.34K |
| CERo Therapeutics Holdings | 759.29K |
| Bio-Path Holdings | 754.46K |